New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2013
14:25 EDTPII, CTRP, RPRX, LXK, SWKSOptions with decreasing volatility: CTRP SWKS RPRX PII LXK
News For CTRP;SWKS;RPRX;PII;LXK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
March 24, 2015
16:32 EDTLXKLexmark to acquire Kofax for $11 per share in cash
Subscribe for More Information
14:18 EDTRPRXRepros Therapeutics April volatility elevated at 144
Repros Therapeutics April call option implied volatility is at 144, May is at 108, August is at 107; compared to its 26-week average of 103 according to Track Data, suggesting large near term price movement
10:17 EDTCTRPOptions with decreasing implied volatility
Options with decreasing implied volatility: FOLD NKTR GES VHC CTRP WSM WLL LNCO NLY ORCL
March 23, 2015
11:22 EDTCTRPOptions with decreasing implied volatility
Options with decreasing implied volatility: FOLD NKTR RUSL XONE GES CTRP WSM NLY ADBE ORCL
March 20, 2015
16:36 EDTCTRPCtrip.com reports Q4 EPS (19c), consensus (28c)
Subscribe for More Information
16:22 EDTCTRPOn The Fly: Closing Wrap
Subscribe for More Information
11:59 EDTCTRPCtrip.com price target raised to $75 from $67 at HSBC
Subscribe for More Information
10:18 EDTCTRPOptions with decreasing implied volatility
Options with decreasing implied volatility: NKTR FOLD RUSL RSX ORCL GES CTRP SLXP WSM SPXS
10:07 EDTCTRPHigh option volume stocks
Subscribe for More Information
09:24 EDTCTRPOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Ctrip.com (CTRP), up 20.1%... Rally Software (RALY), up 17.3%... Nike (NKE), up 5.2%... Darden Restaurants (DRI), up 4.3%... Cheetah Mobile (CMCM), up 3.6%. ALSO HIGHER: Prothena (PRTA), up 40.2% after reporting positive results from Phase 1 study of PRX002... Viggle (VGGL), up 26.9% after confirming receipt of offer from chairman and CEO Robert Sillerman... Intercept Pharmaceuticals (ICPT), up 8.5% after announcing new data analyses from FLINT trial... Biogen Idec (BIIB), up 9.7% after presenting positive interim results from study of aducanumab... Pier 1 Imports (PIR), up 5.2% after being upgraded to Outperform from Perform at Oppenheimer... JinkoSolar (JKS), up 2.8% after announcing that it will supply 75 MWdc of its PV solar modules to Red Horse 2 project and following a strategic collaboration agreement with DuPont (DD). DuPont is up just under 1%. DOWN AFTER EARNINGS: AK Steel (AKS), down 6.8%... Youku Tudou (YOKU), down 4.9%... Tiffany (TIF), down 3.3%. ALSO LOWER: Macerich (MAC), down 7.7% after Simon makes $95.50 per share "best and final" offer.
07:16 EDTCTRPCtrip.com price target raised to $70 from $64 at Brean Capital
Brean Capital raised its price target to $70 from $64 on Ctrip.com citing its secular growth story, aggressive investments, and proven strong execution. Brean Capital reiterated its Buy rating on Ctrip.com shares.
06:06 EDTCTRPStocks with implied volatility above IV index mean; CTRP BIIB
Subscribe for More Information
March 19, 2015
18:05 EDTCTRPCtrip.com sees Q1 revenue RMB 1.01B-RMB 1.03B
14:31 EDTCTRPCtrip.com technical comments ahead of earnings
Subscribe for More Information
10:23 EDTPIIHigh option volume stocks
Subscribe for More Information
March 18, 2015
15:21 EDTPIIPolaris Industries has a conference call hosted by UBS
UBS will host a conference call with CFO Mike Malone and Richard Edwards, Investor Relations on March 20 at 10:30 am.
11:25 EDTSWKSStocks with call strike movement; SWKS MU
Subscribe for More Information
March 16, 2015
15:21 EDTCTRPCtrip.com March volatility elevated into Q4 and outlook
Subscribe for More Information
14:54 EDTRPRXFDA accepting Androxal NDA can be catalyst for Repros, says Brean Capital
Subscribe for More Information
09:28 EDTRPRXRepros Therapeutics reports Q4 EPS (31c), consensus (34c)
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use